The Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease (APPD)
Vision
The Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease (APPD) has been established by a generous donation from the Aufzien Family to promote and enhance research towards better treatment and prevention of Parkinson’s Disease.
Mission
The APPD is an academic Center at The Faculty of Medicine and Sagol School of Neuroscience at Tel Aviv University, which serves as a hub for innovative translational research in Parkinson’s Disease. The center has a grant program and educational activities to support cutting-edge research towards better treatment and prevention, or slowing down of Parkinson’s Disease progression. The Center holds monthly seminars, annual international symposiums and active student exchange programs.
APPD Structure
APPD Directors
Prof. Nir Giladi and Prof. Karen Avraham
Global Advisory Board
Prof. Werner Poewe, Prof. Susan Bressman, and Prof. Jeffry H. Kordower
TAU Scientific Advisory Board
Prof. Sharon Hassin, Prof Drorit Neumann, and Prof. Illana Gozes
Grants Committee
Prof. Nir Giladi, Prof. Karen Avraham, and Prof. Dan Peer
Manager
Rinat Zaslavsky
Grants Manager
Dr. Keren Shatzman
Administration
Alana Sisam and Helen Berman
Prof. Nir Giladi
Nir Giladi, M.D., is a renowned leader in the field of movement disorders and holds The Yehezkel and Batya Sieratzki Chair for Neurology. He is a Full Professor at the School of Medicine at Tel Aviv University and Chairman of the Neurological Institute at the Tel Aviv Sourasky Medical Center.
His research interests are in the field of gait, falls, cognition and genetics in Parkinson’s Disease. Over the past decade, Prof. Giladi has devoted much of his time to research regarding the prodromal stage of Parkinson’s Disease, focusing on biological markers of early detection and predicting the conversion from a subject at risk to a patient with Parkinson’s Disease.
Prof. Karen B. Avraham
Personal and company donations will all be devoted to further support research in the treatment and prevention of Parkinson’s Disease.
To contribute, please contact us.